| 1. |
ATSDR (2001) CERCLA List of Priority Hazardous Substances, ATSDR Information Center, Division of Toxicology, Agency for Toxic Substances and Disease Registry, US Department of Health
and Human Services, Atlanta, GA.
|
| |
| 2. |
Banks, E. C., Ferretti, L. E., and Shucard, D. W. (1997) Effects of low level lead exposure on cognitive function in children:
a review of behavioral, neuropsychological and biological evidence. Neurotoxicology
18, 237–282.
|
| |
| 3. |
Markowitz, M. (2000) Lead poisoning: a disease for the new millennium. Curr. Probl. Pediatr.
30, 62–70.
|
| |
| 4. |
Tong, S., von Schirnding, Y. E., and Prapamontol, T. (2000) Environmental lead exposure: a public health problem of global
dimensions. Bull. World Health Organ.
78, 1068–1077.
|
| |
| 5. |
Needleman, H. L., Gunnoe, C., Leviton, A., et al. (1979) Deficits in psychologic and classroom performance of children with
elevated dentine lead levels. N. Engl. J. Med.
300, 689–695.
|
| |
| 6. |
Stiles, K. M. and Bellinger, D. C. (1993) Neuropsychological correlates of low-level lead exposure in school-age children:
a prospective study. Neurotoxicol. Teratol.
15, 27–35.
|
| |
| 7. |
Schwartz, J. (1994) Low-level lead exposure and children’s IQ: a meta-analysis and search for threshold. Environ. Res.
65, 42–6555.
|
| |
| 8. |
Needleman, H. L., Riess, J. A., Tobin, M. J., Biesecker, G. E., and Greenhouse, J.B. (1996) Bone lead levels and delinquent
behavior. J. Am. Med. Assoc.
275, 363–369.
|
| |
| 9. |
Centers for Disease Control and Prevention (1991) Preventing lead poisoning in young children: a statement by the Centers
for Disease Control. US Department of Health and Human Services, Atlanta, GA.
|
| |
| 10. |
United States Environmental Protection Agency (2000) America’s Children and the Environment: A First View of Available Measures, US EPA, Research Triangle Park, NC.
|
| |
| 11. |
Duckett, S., Galle, P., and Kradin, R. (1977) The relationship between Parkinson syndrome and vascular siderosis: an electron
microprobe study. Ann. Neurol.
2, 225–229.
|
| |
| 12. |
Gorell, J. M., Johnson, C. C., Rybicki, B. A., et al. (1999) Occupational exposure to manganese, copper, lead, iron, mercury
and zinc and the risk of Parkinson’s disease. Neurotoxicology
20, 239–248.
|
| |
| 13. |
Gorell, J. M., Rybicki, B. A., Johnson, C. C., and Peterson, E. L. (1999) Occupational metal exposures and the risk of Parkinson’s
disease. Neuroepidemiology
18, 303–308.
|
| |
| 14. |
Kuhn, W., Winkel, R., Woitalla, D., Meves, S., Przuntek, H., and Müller T. (1998) High prevalence of parkinsonism after occupational
exposure to leadsulfate batteries. Neurology
50, 885–1886.
|
| |
| 15. |
Crofton, K. M., Taylor, D. H., Bull, R. J., Sivulka, D. J., and Lutkenhoff, S. D. (1980) Developmental delays in exploration
and locomotor activity in male rats exposed to low level lead. Life Sci.
26, 823–831.
|
| |
| 16. |
Alfano, D. P. and Petit, T. L. (1982) Neonatal lead exposure alters the dendritic development of hippocampal dentate granule
cells. Exp. Neurol.
75, 275–288.
|
| |
| 17. |
McCauley, P. T., Bull, R. J., Tonti, A. P., et al. (1982) The effect of prenatal and postnatal lead exposure on neonatal synaptogenesis
in rat cerebral cortex. Toxicol. Environ. Health
10, 639–651.
|
| |
| 18. |
Cookman, G. R., King, W., and Regan, C. M. (1987) Chronic low-level lead exposure impairs embryonic to adult conversion of
the neural cell adhesion molecule. J. Neurochem.
49, 399–403.
|
| |
| 19. |
Reuhl, K. R., Rice, D. C, Gilbert, S. G., and Mallett, J. (1991) Effects of chronic developmental lead exposure on monkey
neuroanatomy: visual system. Toxicol. Appl. Pharmacol.
99, 501–509.
|
| |
| 20. |
Patrick, G. W. and Anderson, W. J. (1995) Dendritic alterations of cortical pyramidal neurons in postnatally lead-exposed
kittens: a Golgi-Cox study. Dev. Neurosci.
17, 219–229.
|
| |
| 21. |
Kern, M. and Audesirk, G. (1995) Inorganic lead may inhibit neurite development in cultured rat hippocampal neurons through
hyperphosphorylation. Toxicol. Appl. Pharmacol.
134, 111–123.
|
| |
| 22. |
Ishihara, K., Alkondon, M., Montes, J. G., and Albuquerque, E. X. (1995) Ontogenically related properties of NMDA receptors
in rat hippocampal neurons and the age-specific sensitivity of developing neurons to lead. J. Pharm. Exp. Ther.
273, 1459–1470.
|
| |
| 23. |
Cline, H. T., Witte, S., and Jones, K. W. (1996) Low lead levels stunt neuronal growth in a reversible manner. Proc. Natl. Acad. Sci. USA
93, 9915–9920.
|
| |
| 24. |
Gilbert, M. E., Mack, C. M., and Lasley, S. M. (1996) Chronic developmental lead exposure increases threshold for long-term
potentiation in the rat dentate gyrus in vivo. Brain Res.
736, 118–124.
|
| |
| 25. |
Gilbert, M. E. and Mack, C. M. (1998) Chronic developmental lead exposure accelerates decay of long-term potentiation in rat
dentate gyrus in vivo. Brain Res.
789, 139–149.
|
| |
| 26. |
Omelchenko, I. A., Nelson, C. S., Marino, J. L., and Allen, C. N. (1996) The sensitivity of NMDA receptors to lead inhibition
is dependent on the receptor subunit composition. J. PET
278, 15–20.
|
| |
| 27. |
Omelchenko, I. A., Nelson, C. S., and Allen, C. N. (1997) Lead inhibition of NMDA receptors containing NR2A, NR2C and NR2D
subunits. J. PET
282, 1458–1464.
|
| |
| 28. |
Wilson, M. A., Johnston, M. V., Goldstein, G. W., and Blue, M. E. (2000) Neonatal lead exposure impairs development of rodent
barrel field cortex. Proc. Natl. Acad. Sci. USA
97, 5540–5545.
|
| |
| 29. |
Windebank, A. J. (1986) Specific inhibition of myelination by lead in vitro; comparison with arsenic, thallium, and mercury.
Exp. Neurol.
94, 203–212.
|
| |
| 30. |
Tang, H.-W., Yan, H.-L., Hu, X.-H., Liang, Y.-X., and Shen, X.-Y. (1996) Lead cytotoxicity in primary cultured rat astrocytes
and Schwann cells. J. Appl. Toxicol.
16, 187–196.
|
| |
| 31. |
Deng, W., McKinnon, R. D., and Poretz, R. D. (2001) Lead exposure delays the differentiation of oligodendroglial progenitors
in vitro. Toxicol. Appl. Pharmacol.
174, 235–244.
|
| |
| 32. |
Tiffany-Castiglioni, E., Zmudzki, J., Wu, J.-N., and Bratton, G. R. (1987) Effects of lead treatment on intracellular Cu and
Fe in cultured astroglia. Metab. Brain Dis.
2, 61–79.
|
| |
| 33. |
Engle, M. J. and Volpe, J. J. (1990) Glutamine synthetase activity of developing astrocytes is inhibited in vitro by very
low concentrations of lead. Dev. Brain Res.
55, 283–287.
|
| |
| 34. |
Sierra, E. M. and Tiffany-Castiglioni, E. (1991) Reduction of glutamine synthetase activity in astroglia exposed in culture
to low levels of inorganic lead. Toxicology
65, 295–304.
|
| |
| 35. |
Dave, V., Vitarella, D., Aschner, J. L., Fletcher, P., Kimelberg, H. K., and Aschner, M. (1993) Lead increases inositol 1,4,5-trisphosphate
levels but does not interfere with calcium transients in primary rat astrocytes. Brain Res.
618, 9–18.
|
| |
| 36. |
Kerper, L. E. and Hinkle, P. M. (1997) Cellular uptake of lead is activated by depletion of intracellular calcium stores.
J. Biol. Chem.
272, 8346–8352.
|
| |
| 37. |
Legare, M. E., Barhoumi, R., Hebert, E., Bratton, G. R., Burghardt, R. C., and Tiffany-Castiglioni, E. (1998) Analysis of
Pb2+ entry into cultured astroglia. Toxicol. Sci.
46, 90–100.
|
| |
| 38. |
Rowles, T. K., Womac, C., Bratton, G. R., and Tiffany-Castiglioni, E. (1989) Interaction of lead and zinc in cultured astroglia.
Metab. Brain Dis.
4, 187–201.
|
| |
| 39. |
Qian, Y., Tiffany-Castiglioni, E., and Harris, E. D. (1995) Copper transport and kinetics in cultured C6 rat glioma cells.
Am. J. Physiol.
269, C892–C898.
|
| |
| 40. |
Qian, Y., Mikeska, G., Harris, E. D., Bratton, G. R., and Tiffany-Castiglioni, E. (1999) Effect of lead exposure and accumulation
on copper homeostasis in cultured C6 rat glioma cells. Toxicol. Appl. Pharmacol.
158, 41–49.
|
| |
| 41. |
Legare, M. E., Barhoumi, R., Burghardt, R. C., and Tiffany-Castiglioni, E. (1993) Low-level lead exposure in cultured astroglia:
identification of cellular targets with vital fluorescent probes. Neurotoxicology
14, 267–272.
|
| |
| 42. |
Qian, Y., Harris, E. D., Zheng, Y., and Tiffany-Castiglioni, E. (2000) Lead targets GRP78, a molecular chaperone, in C6 rat
glioma cells. Toxicol. Appl. Pharmacol.
163, 260–266.
|
| |
| 43. |
Qian, Y., Falahatpsheh, M. H., Zheng, Y., Ramos, K. S., and Tiffany-Castiglioni, E. (2001) Induction of 78 kD glucose-regulated
protein (GRP 78) expression and redox-regulated transcription factor activity by lead and mercury in C6 rat glioma cells.
Neurotox. Res.
3, 581–589.
|
| |
| 44. |
Qian, Y. and Tiffany-Castiglioni, E. (2003) Lead-induced endoplasmic reticulum (ER) stress responses in the nervous system.
Neurochem. Res.
28, 153–162.
|
| |
| 45. |
Holtzman, D., de Vries, C., Nguyen, H., Olson, J., and Bensch, K. (1984) Maturation of resistance to lead encephalopathy:
cellular and subcellular mechanisms. Neurotoxicology
5, 97–124.
|
| |
| 46. |
Holtzman, D., Olson, J., de Vries, C., and Bensch, K. (1987) Lead toxicity in primary cultured cerebral astrocytes and cerebellar
granule neurons. Toxicol. Appl. Pharmacol.
89, 211–235.
|
| |
| 47. |
Tiffany-Castiglioni, E. (1993) Cell culture models for lead toxicity in neuronal and glial. Neurotoxicology
4, 513–536.
|
| |
| 48. |
Tiffany-Castiglioni, E., Legare, M.E., Schneider, L. A., Hanneman, W. H., Zenger, E., and Hong, S. J. (1996) Astroglia and
neurotoxicity, in The Role of Glia in Neurotoxicity (Aschner, M. and Kimelberg, H. K., eds.) CRC, Boca Raton, FL, pp. 175–200.
|
| |
| 49. |
Yip, R. and Dallman, P. R. (1984) Developmental changes in erythrocyte protoporphyrin: the roles of iron deficiency and lead
toxicity. J. Pediatr.
104, 710–730.
|
| |
| 50. |
Yip, R. (1990) Multiple interactions between childhood iron deficiency and lead poisoning: evidence that childhood lead poisoning
is an adverse consequence of iron deficiency, in Recent Knowledge on Iron and Folate Deficiencies in the World (Hercberg, S., Galan, P., and Dupin, H., eds.), Colloque INSERM, Paris, pp. 523–532.
|
| |
| 51. |
O’Flaherty, E. J. (1995) Physiologically based models for bone-seeking elements. V. Lead absorption and disposition in childhood.
Toxicol. Appl. Pharmacol.
131, 297–308.
|
| |
| 52. |
Scortegagna, M., Chikhale, E., and Hanbauer, I. (1998) Lead exposure increases oxidative stress in serum deprived E14 mesencephalic
cultures. Role of metallothionein and glutathione. Restor. Neurol. Neurosci.
12, 95–101.
|
| |
| 53. |
Liu, M. Y., Hsieh, W. C., and Yang, B. C. (2000) In vitro aberrant gene expression as the indicator of lead-induced neurotoxicity
in U-373MG cells. Toxicology
147, 59–64.
|
| |
| 54. |
Long, G. J., Rosen, J. F., and Schanne, F. A. X. (1994) Lead activation of protein kinase C from rat brain. J. Biol. Chem.
269, 834–837.
|
| |
| 55. |
Srivastava, D., Hurwitz, R. L., and Fox, D. A. (1995) Lead-and calcium-mediated inhibition of bovine rod cGMP phosphodiesterase:
interactions with magnesium. Toxicol. Appl. Pharmacol.
134, 43–52.
|
| |
| 56. |
Tomsig, J. L. and Suszkiw, J. B. (1995) Multisite interactions between Pb+2 and protein kinase C and its role in norepinephrine release from bovine adrenal chromaffin cells. J. Neurochem.
64, 2667–2773.
|
| |
| 57. |
Westerink, R. H. S. and Vijverberg, H. P. M. (2002) Ca+2-independent vesicular catecholamine release in PC12 cells by nanomolar concentrations of Pb+2. J. Neurochem.
80, 861–873.
|
| |
| 58. |
Tomsig, J. L. and Suszkiw, J. B. (1990) Pb-induced secretion from bovine chromaffin cells: fura-2 as a probe for Pb2+. Am. J. Physiol.
259, C762–C768.
|
| |
| 59. |
Legare, M. E., Castiglioni, A. J., Jr., Rowles, T. K., Calvin, J. A., Snyder-Armstead, C., and Tiffany-Castiglioni, E. (1993)
Morphological alterations of neurons and astrocytes in guinea pigs exposed to low levels of inorganic lead. NeuroToxicology
14(1), 77–80.
|
| |
| 60. |
Breen, K. and Regan, C. M. (1988) Developmental control of N-CAM sialylation state by Golgi sialyltransferase isoforms. Development
104, 147–154.
|
| |
| 61. |
Breen, K. and Regan, C. M. (1988) Lead stimulates Golgi sialyltransferase at times coincident with the embryonic to adult
conversion of the neural cell adhesion molecule. Toxicology
49, 71–76.
|
| |
| 62. |
Regan, C. M. (1993) Neural cell adhesion molecules, neuronal development, and lead toxicity. Neurotoxicology
14, 69–74.
|
| |
| 63. |
Audesirk, T., Audesirk, G., Ferguson, C., and Shugarts, D. (1991) Effects of inorganic lead on the differentiation and growth
of cultured hippocampal and neuroblastoma cells. Neurotoxicology
12, 529–538.
|
| |
| 64. |
Kern, M., Audesirk, T., and Audesirk, G. (1993) Effects of inorganic lead on the differentiation and growth of cortical neurons
in culture. Neurotoxicology
14, 319–328.
|
| |
| 65. |
Williams, T. M., Ndifor, A. M., Neary, J. T., and Reams-Brown, R. R. (2000) Lead enhances NGF-induced neurite outgrowth in
PC12 cells by potentiating ERK/MAPK activation. Neurotoxicology
21, 1081–1090.
|
| |
| 66. |
Crumpton, T., Atkins, D., Zawia, N., and Barone, S. (2001) Lead exposure in pheochromocytoma (PC12) cells alters neural differentiation
and Sp1 DNAbinding. Neurotoxicology
22, 49–62.
|
| |
| 67. |
Tepass, U., Truong, K., Godt, D., Ikura, M., and Peifer, M. (2000) Cadherins in embryonic and neural morphogenesis. Nature Rev.
1, 91–100.
|
| |
| 68. |
Dey, P. M., Burger, J., Gochfeld, M., and Reuhl, K. R. (2000) Developmental lead exposure disturbs expression of synaptic
neural cell adhesion molecules in herring gull brains. Toxicology
146, 137–147.
|
| |
| 69. |
Prozialeck, W. C., Grunwald G. B., Dey, P. M., Reuhl, K. R., and Parrish, A. R. (2002) Cadherins and NCAM as potential targets
in metal toxicity. Toxicol. Appl. Pharmacol.
182, 255–265.
|
| |
| 70. |
Zawia, N. H. and Harry, G. J. (1996) Developmental exposure to lead interferes with glial and neuronal differential gene expression
in the rat cerebellum. Toxicol. Appl. Pharmacol.
138, 43–47.
|
| |
| 71. |
Zawia, N. H., Evers, L. B., and Harry, G. J. (1994) Developmental profiles of ornithine decarboxylase activity in the hippocampus,
neocortex and cerebellum: modulation following lead exposure. Int. J. Dev. Neurosci.
12, 25–30.
|
| |
| 72. |
Zawia, N. H., Evers, L. B., Kodavanti, P. R., and Harry, G. J. (1994) Modulation of developmental cerebellar ornithine decarboxylase
activity by lead-acetate. Neurotoxicology
15, 903–911.
|
| |
| 73. |
Murray, B. A., Hemperly, J. J., Prediger, E. A., Edelman, G. M., and Cunningham, B. A. (1986) Alternatively spliced mRNAs
code for different polypeptide chains of the chicken neural cell adhesion molecule (N-CAM). J. Cell Biol.
102, 189–193.
|
| |
| 74. |
Jorgensen, O. S. (1995) Neural cell adhesion molecule (NCAM) as a quantitative marker in synaptic remodeling. Neurochem. Res.
20, 533–547.
|
| |
| 75. |
Noble, M., Albrechtsen, M., Moller, C., et al. (1985) Glial cells express NCAM/ D2-CAM-like polypeptides in vitro. Nature
316, 725–748.
|
| |
| 76. |
Moran, N. M. and Bock, E. (1988) Characterization of the kinetics of neural cell adhesion molecule homophilic binding. FEBS Lett.
242, 121–124.
|
| |
| 77. |
Edelman, G. M. and Chuong, C.-M. (1982) Embryonic to adult conversion of neural cell adhesion molecules in normal and staggerer
mice. Proc. Natl. Acad. Sci. USA
79, 7036–7040.
|
| |
| 78. |
Ronn, L. C. B., Hartz, B. P., and Bock, E. (1998) The neural cell adhesion molecule (NCAM) in development and plasticity of
the nervous system. Exp. Gerontol.
33, 853–864.
|
| |
| 79. |
Davey, F. D. and Breen, K. C. (1998) Stimulation of sialyltransferase by subchronic low-level lead exposure in the developing
nervous system. A potential mechanism of teratogen action. Toxicol. Appl. Pharmacol.
151, 16–21.
|
| |
| 80. |
Riehl, R., Johnson, K., Bradley, R., et al. (1996) Cadherin function is required for axon outgrowth in retinal ganglion cells
in vivo. Neuron
17, 837–848.
|
| |
| 81. |
Inoue, A. and Sanes, J. R. (1997) Lamina-specific connectivity in the brain: regulation by N-cadherin, neurotrophins, and
glycoconjugates. Science
276, 1428–1431.
|
| |
| 82. |
Tanaka, H., Shan, W., Phillips, G. R., et al. (2000) Molecular modification of N-cadherin in response to synaptic activity.
Neuron
25, 93–107.
|
| |
| 83. |
Fannon, A. M. and Colman, D. R. (1996) A model for central synaptic junctional complex formation based on the differential
adhesive specificities of the cadherins. Neuron
17, 423–434.
|
| |
| 84. |
Uchida, N., Honjo, Y., Johnson, K. R., Wheelock, M. J., and Takeichi, M. (1996) The catenin/cadherin adhesion system is localized
in synaptic junctions bordering transmitter release zones. J. Cell Biol.
135, 767–779.
|
| |
| 85. |
Zhou, M., Tian, X., and Suszkiw, J. B. (2000) Developmental stage-dependent protective effect of NGF against lead cholinotoxicity
in the rat septum. Brain Res.
866, 268–273.
|
| |
| 86. |
Reinhard, E., Nedivi, E., Wegner, J., Skene, J. H. P., and Westerfield, M. (1994) Neural selective activation and temporal
regulation of a mammalian GAP-43 promotor in zebrafish. Development
120, 1767–1775.
|
| |
| 87. |
Bernstein, H.-G. and Muller, M. (1999) The cellular localization of the l-ornithine decarboxylase/polyamine sytemin normal and diseased central nervous system. Prog. Neurobiol.
57, 485–505.
|
| |
| 88. |
Klekner, A., Rohn, A. G., Schillinger, G., Schroder, R., Klug, N., and Ernestus, R. I. (2001) ODC mRNA as a prognostic factor
for predicting recurrence in meningiomas. J. Neurooncol.
53, 67–75.
|
| |
| 89. |
Hilliard, A., Ramesh, A., and Zawia, N. H. (1999) Correlation between leadinduced changes in cerebral ornithine decarboxylase
and protein kinase C activities during development and in cultured PC12 cells. Int. J. Dev. Neurosci.
17, 777–785.
|
| |
| 90. |
Toews, A. D., Krigman, M. R., Thomas, D. J., and Morell, P. (1980) Effect of inorganic lead exposure on myelination in the
rat. Neurochem. Res.
5, 605–616.
|
| |
| 91. |
Toews, A. D., Blaker, W. D., Thomas, D. J., et al. (1983) Myelin deficit produced by early postnatal exposure to inorganic
lead or triethyltin are persistent. J. Neurochem.
41, 816–822.
|
| |
| 92. |
Harry, G. J., Toews, A. D., Kirgman, M. R., and Morell, P. (1985) The effect of lead toxicity and milk deprivation on myelination
in the rat. Toxicol. Appl. Pharmacol.
77, 458–464.
|
| |
| 93. |
Sundstr^m, R. and Karlsson, B. (1987) Myelin basic protein in brains of rats with low dose lead encephalopathy. Arch. Toxicol.
59, 341–345.
|
| |
| 94. |
Seppalainen, A. M., Hernberg, S., Vesanto, R., and Kock, B. (1983) Early neurotoxic effects of occupational lead exposure:
a prospective study. Neurotoxicology
4(2), 181–192.
|
| |
| 95. |
Araki, S., Sato, H., Yokoyama, K., and Murata, K. (2000) Subclinical neurophysiological effects of lead: a review on peripheral,
central, and autonomic nervous system effects in lead workers. Am. J. Ind. Med.
37, 193–204.
|
| |
| 96. |
Harry, G. J., Billingsley, M., Bruinink, A., et al. (1998) In vitro techniques for the assessment of neurotoxicity. Environ. Health Perspect.
106(Suppl.), 131–158.
|
| |
| 97. |
Dabrowska-Bouta, B., Sulkowski, G., Bartosz, G., Walski, M., and Rafalowska, U. (1999) Chronic lead intoxication affects the
myelin membrane status in the central nervous system of adult rats. J. Mol. Neurosci.
13, 127–139.
|
| |
| 98. |
Wu, J.-N. and Tiffany-Castiglioni, E. (1987) Reduction by lead of hydrocortisone-induced glycerol phosphate dehydrogenase
activity in cultured rat oligodendroglia. In Vitro Dev. Cell. Biol.
23, 765–774.
|
| |
| 99. |
Sierra, E. M., Rowles, T. K., Martin, J., Bratton, G. R., Womac, C., and Tiffany-Castiglioni, E. (1989) Low level lead neurotoxicity
in a pregnant guinea pig model: Neuroglial enzyme activities and brain trace metal concentrations. Toxicology
59, 81–96.
|
| |
| 100. |
Gordon, M. N., Kumar, S., Espinosa de los Monteros, A., and de Vellis, J. (1992) Ontogeny of glycerol phosphate dehydrogenase-positive
oligodendrocytes in rat brain. Impaired differentiation of oligodendrocytes in the myelin deficient mutant rat. Int. J. Devel. Neurosci.
10, 243–253.
|
| |
| 101. |
Deng, W. and Poretz, R. D. (2002) Protein kinase C activation is required for the lead-induced inhibition of proliferation
and differentiation of cultured oligodendroglial progenitor cells. Brain Res.
929, 87–95.
|
| |
| 102. |
Yim, S. H., Farrer, R. G., and Quarles, R. H. (1995) Expression of glycolipids and myelin-associated glycoprotein during the
differentiation of oligodendrocytes: comparison of the CG-4 glial cell line to primary cultures. Dev. Neurosci.
17, 171–180.
|
| |
| 103. |
Deng, W. and Poretz, R. D. (2001) Lead exposure affects levels of galactolipid metabolic enzymes in the developing rat brain.
Toxicol. Appl. Pharmacol.
172, 98–107.
|
| |
| 104. |
Deng, W. and Poretz, R. D. (2001) Lead alters the developmental profile of the galactolipid metabolic enzymes in cultured
oligodendrocyte lineage cells. Neurotoxicology
22, 429–437.
|
| |
| 105. |
Poretz, R. D., Yang, A., Deng, W., and Manowitz, P. (2000) The interaction of lead exposure and arylsulfatase A genotype affects
sulfatide catabolism in human fibroblasts. Neurotoxicology
21, 379–387.
|
| |
| 106. |
Chen, X. G. and Poretz, R. D. (2001) Lead causes human fibroblasts to missort arylsulfatase A. Toxicology
163, 107–114.
|
| |
| 107. |
S·nchez, I., Hassinger, L., Paskevich, P. A., Shine, H. D., and Nixon, R. A. (1996) Oligodendroglia regulate the regional
expansion of axon caliber and local accumulation of neurofilaments during development independently of myelin formation. J. Neurosci.
16, 5095–5105.
|
| |
| 108. |
Sortwell, C. E., Daley, B. F., Pitzer, M. R., McGuire, S. O., Sladek, J. R., and Collier, T. J. (2000) Oligodendrocyte-type
2 astrocyte-derived trophic factors increase survival of developing dopamine neurons through the inhibition of apoptotic cell
death. J. Comp. Neurol.
426, 143–153.
|
| |
| 109. |
Kaplan, M. R., Meyer-Franke, A., Lambert, S., et al. (1997) Induction of sodium channel clustering by oligodendrocytes. Nature
386, 724–728.
|
| |
| 110. |
Taniike, M., Mohri, I., Eguchi, N., Beuckmann, C. T., Suzuki, K., and Urade, Y. (2002) Perineuronal oligodendrocytes protect
against neuronal apoptosis through the production of lipocalin-type prostaglandin D synthase in a genetic demyelinating model.
J. Neurosci.
22, 4885–4896.
|
| |
| 111. |
Zawia, N. H. and Harry, G. J. (1995) Exposure to lead-acetate modulates the developmental expression of myelin genes in the
rat frontal lobe. Int. J. Dev. Neurosci.
13, 639–644.
|
| |
| 112. |
Popko, B., Pearl, D. K., Walker, D. M., et al. (2002) Molecular markers that identify human astrocytomas and oligodendrogliomas.
J. Neuropathol. Exp. Neurol.
61, 329–338.
|
| |
| 113. |
Anttila A. Heikkila P. Nykyri E. et al. (1996) Risk of nervous system cancer among workers exposed to lead. J. Occup. Environ. Med.
38, 131–136.
|
| |
| 114. |
Cohen, R. D., Bowser, D. H., and Costa, M. (1996) Carcinogenicity and genotoxicity of lead, beryllium, and other metals, in
Toxicology of Metals (Chang, L. W., Magos, L., and Suzuki, T., eds.), CRC/Lewis, Boca Raton, FL, pp. 253–284.
|
| |
| 115. |
Johnson, F. M. (1998) The genetic effects of environmental lead. Mutat. Res.
410, 123–140.
|
| |
| 116. |
Gencic, S. and Hudson, L. D. (1990) conservative amino acid substitution in the myelin proteolipid protein of jimpymsd mice.
J. Neurosci.
10, 117–124.
|
| |
| 117. |
Henson, J., Saffer, J., and Furneaux, H. (1992) The transcription factor Sp1 binds to the JC virus promoter and is selectively
expressed in glial cells in human brain. Ann. Neurol.
32, 72–77.
|
| |
| 118. |
Kumar, A. P., Mar, P. K., Zhao, B., Montgomery, R. L., Kang, D. C., and Butler, A. P. (1995) Regulation of rat ornithine decarboxylase
promoter activity by binding of transcription factor Sp1. J. Biol. Chem.
270, 4341–4348.
|
| |
| 119. |
Bai, G. and Kusiak, J. W. (1995) Functional analysis of the proximal 5′-flanking region of the N-methyl-d-aspartate receptor subunit gene, NMDAR1. J. Biol. Chem.
270, 7737–7744.
|
| |
| 120. |
Saffer, J. D., Jackson, S. P., and Annarella, M. B. (1991) Developmental expression of Sp1 in the mouse. Mol. Cell Biol.
11, 2189–2199.
|
| |
| 121. |
Zawia, N. H., Sharan, R., Brydie, M., Oyama, T., and Crumpton, T. (1998) Sp1 as a target site for metal-induced perturbations
of transcriptional regulation of developmental brain gene expression. Dev. Brain Res.
107, 291–298.
|
| |
| 122. |
Razmiafshari, M. and Zawia, N. H. (2000) Utilization of a synthetic peptide as a tool to study the interaction of heavy metals
with the zinc finger domain of proteins critical for gene expression in the developing brain. Toxicol. Appl. Pharmacol.
166, 1–12.
|
| |
| 123. |
Razmiafshari, M., Kao, J., ďAvignon, A., and Zawia, N. H. (2001) NMR identification of heavy metal-binding sites in a synthetic
zinc finger peptide: toxicological implications for the interactions of xenobiotic metals with zinc finger proteins. Toxicol. Appl. Pharmacol.
172, 1–10.
|
| |
| 124. |
Miskimins, R. and Miskimins, W. K. (2001) A role for an AP-1-like site in the expression of the myelin basic protein gene
during differentiation. Int. J. Dev. Neurosci.
19, 85–91.
|
| |
| 125. |
Tiffany-Castiglioni, E., Sierra, E. M., Wu, J.-N., and Rowles, T. K. (1989) Lead toxicity in neuroglia. Neurotoxicology
10, 383–410.
|
| |
| 126. |
Tiffany-Castiglioni, E., Legare, M. E., Schneider, L. A., et al. (1996) Heavy metal effects on glia, in Methods in Neurosciences, Volume 30 (Regino Perez-Polo, J., ed.) Academic, New York, pp. 135–165.
|
| |
| 127. |
Tiffany-Castiglioni, E. and Qian, Y. (2001) Astroglia as metal depots: molecular mechanisms for metal accumulation, storage
and release. Neurotoxicology
22, 577–592.
|
| |
| 128. |
Lidsky, T. I. and Schneider, J. S. (2003) Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain
126, 5–19.
|
| |
| 129. |
Opanashuk, L. A. and Finkelstein, J. N. (1995) Induction of newly synthesized proteins in astroglial cells exposed to lead.
Toxicol. Appl. Pharmacol.
131, 21–30.
|
| |
| 130. |
Opanashuk, L. A. and Finkelstein, J. N. (1995) Relationship of lead-induced proteins to stress response proteins in astroglial
cells. J. Neurosci. Res.
42, 623–632.
|
| |
| 131. |
Selvin-Testa, A., Capani, F., Loidl, C. F., Lopez, E. M., and Pecci-Saavedra, J. (1997) Prenatal and postnatal lead exposure
induces 70 kDa heat shock protein in young rat brain prior to changes in astrocyte cytoskeleton. Neurotoxicology
18, 805–817.
|
| |
| 132. |
Li, P. and Rossman, T. G. (2001) Genes upregulated in lead-resistant glioma cells reveal possible targets for lead-induced
developmental neurotoxicity. Toxicol. Sci.
64, 90–99.
|
| |
| 133. |
Bradbury, M. W. B. and Deane, R. (1993) Permeability of the blood-brain barrier to lead. Neurotoxicology
14, 131–136.
|
| |
| 134. |
Lindahl, L., Bird, L., Legare, M. E., Mikeska, G., Bratton, G. R, and Tiffany-Castiglioni, E. (1999) Differential ability
of astroglia and neuronal cells to accumulate lead: dependence on cell type and on degree of differentiation. Toxicol. Sci.
50, 236–243.
|
| |
| 135. |
Thomas, J. A., Dallenbeck, F. D., and Thomas, M. (1973) The distribution of radioactive lead [210Pb] in the cerebellum of developing rats. J. Pathol.
109, 45–50.
|
| |
| 136. |
Shirabe, T. and Hirano, A. (1977) X-ray microanalytical studies of lead-implanted rat brains. Acta Neuropathol.
40, 189–192.
|
| |
| 137. |
Zurich, M. G., Monnet-Tschudi, F., Bérode, M., and Honegger, P. (1998) Lead acetate toxicity in vitro: dependence on the cell
composition of the cultures. Toxicol. In Vitro
12, 191–196.
|
| |
| 138. |
Vaguera-Orte, J., Cervos-Navarro, J., Martin-Giron, F., and Becerra-Ratia, J. (1981) Fine structure of the perivascular-limiting
membrane, in Cerebral Microcirculation and Metabolism (Cervos-Navarro, J. and Fitschka, E., eds.), Raven, New York, pp. 129–138.
|
| |
| 139. |
Young, J. K., Garvey, J. S., and Huang, P. C. (2000) Glial immunoreactivity for metallothionein in the rat brain. Glia
4, 602–620.
|
| |
| 140. |
Penkowa, M., Nielsen, H., Hidalgo, J., Bernth, N., and Moos, T. (1999) Distribution of metallothionein I+II and vesicular
zinc in the developing central nervous system: Correlative study in the rat. J. Comp. Neurol.
412, 303–318.
|
| |
| 141. |
Masters, B. A., Quaife, C. J., Erickson, J. C., et al. (1994) Metallothionein III is expressed in neurons that sequester zinc
in synaptic vesicles. J. Neurosci.
14, 5844–5857.
|
| |
| 142. |
Erickson, J. C., Hollopeter, G., Thomas, S. A., Froelick, G. J., and Palmiter, R. D. (1997) Disruption of the metallothionein-III
gene in mice: analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures. J. Neurosci.
17, 1271–1281.
|
| |
| 143. |
Carrasco, J., Giralt, M., Molinero, A., Penkowa, M., Moos, T., and Hidalgo, J. (1999) Metallothionein (MT)-III: generation
of polyclonal antibodies, comparison with MT-I+II in the freeze lesioned rat brain and in a bioassay with astrocytes, and
analysis of Alzheimer’s disease brains. J. Neurotrauma
16, 1115–1129.
|
| |
| 144. |
Aschner, M., Conklin, D. R. Yao, C. P., Allen, J. W., and Tan, K. H. (1998) Induction of astrocyte metallothioneins (Mts)
by zinc confers resistance against the acute cytotoxic effects of methylmercury on cell swelling, Na+ uptake, and K+ release. Brain Res.
813, 254–261.
|
| |
| 145. |
Kramer, K. K., Zoelle, J. T., and Klaassen, C. D. (1996) Induction of metallothionein mRNA and protein in primary murine neuron
cultures. Toxicol. Appl. Pharmacol.
141, 1–7.
|
| |
| 146. |
Raps, S. P., Lai, J. C., Hertz, L., and Cooper, A. J. (1989) Glutathione is present in high concentrations in cultured astrocytes
but not in cultured neurons. Brain Res.
493, 398–401.
|
| |
| 147. |
Slivka, A., Mytilineou, C., and Cohen, G. (1987) Histochemical evaluation of glutathione in brain. Brain Res.
409, 275–284.
|
| |
| 148. |
Philbert, M. A., Beiswanger, C. M., Waters, D. K., Reuhl, K. R., and Lowndes, H. E. (1991) Cellular and regional distribution
of reduced glutathione in the nervous system of the rat: histochemical localization by mercury orange and o-phthaldialdhyde-induced histofluorescence. Toxicol. Appl. Pharmacol.
107, 215–227.
|
| |
| 149. |
Klomp, L., Farhangrazi, Z., Dugan, L., and Gitlin, J. (1996) Ceruloplasmin gene expression in the murine central nervous system.
J. Clin. Invest.
98, 207–215.
|
| |
| 150. |
Patel, B. N. and David, S. (1997) A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian
astrocytes. J. Biol. Chem.
272, 20,185–20,190.
|
| |
| 151. |
Kaler, S. G. and Schwartz, J. P. (1998) Expression of the menkes disease homolog in rodent neuroglial cells. Neurosci. Res. Commun.
23, 61–66.
|
| |
| 152. |
Qian, Y., Tiffany-Castiglioni, E., and Harris, E. D. (1997) A Menkes P-type ATPase involved in copper homeostasis in the central
nervous system of the rat. Mol. Brain. Res.
48, 60–66.
|
| |
| 153. |
Niklowitz, W. J. (1980) Toxicology of lead, in Advances in Neurotoxicology (Manso, L., Lory, N., Lacasse, Y., and Roche, L., eds.), Permagon, New York, pp. 27–43.
|
| |
| 154. |
Rehman, S.-U. and Chandra, O. (1984) Regional interrelationships of zinc, copper, and lead in the brain following lead intoxication.
Bull. Environ. Contam. Toxicol.
32, 157–165
|
| |
| 155. |
Tiffany-Castiglioni, E., Garcia, D. M., Wu, J. N., Zmudzki, J., and Bratton, G. R. (1988) Effects of lead on viability and
intracellular metal content of C6 rat glioma cells. J. Toxicol. Environ. Health
23, 267–279.
|
| |
| 156. |
Wedler, F. C. and Denman, R. B. (1984) Glutamine synthetase: the major Mn(II) enzyme in mammalian brain. Curr. Topics Cell. Regul.
24, 153–169.
|
| |
| 157. |
Norenberg, M. D. and Martinez-Hernandez, A. (1979) Fine structural localization of glutamine synthetase in astrocytes of rat
brain. Brain Res.
161, 303–310.
|
| |
| 158. |
Kodama, H., Meguro, Y., Abe, T., et al. (1991) Genetic expression of Menkes disease in cultured astrocytes of the macular
mouse. J. Inherit. Metab. Dis.
14, 896–901.
|
| |
| 159. |
Kodama, H. (1993) Recent developments in Menkes disease. J. Inherit. Metab. Dis.
16, 791–799.
|
| |
| 160. |
Hartmann, H. A. and Evenson, M. A. (1992) Deficiency of copper can cause neuronal degeneration. Med. Hypotheses
38, 75–85.
|
| |
| 161. |
Scortegagna, M. and Hanbauer, I. (2000) Increase AP-1 binding activity and nuclear REF-1 accumulation in lead-exposed primary
cultures of astroglia. Neurochem. Res.
25, 861–866.
|
| |
| 162. |
Buchner, J. (1999). Hsp90 & Co.—a holding for folding. Trends Biochem. Sci.
24, 36–141.
|
| |
| 163. |
Caplan, A. J. (1999). Hsp90’s secrets unfold: new insights from structural and functional studies. Cell Biol.
9, 262–268.
|
| |
| 164. |
Lee, A. S. (1992) Mammalian stress response: induction of the glucose-regulated protein family. Curr. Opin. Cell Biol.
4, 267–273.
|
| |
| 165. |
Gething, M. J. (1997) Guidebook to Molecular Chaperones and Protein-Folding Catalysts. Oxford University Press, Oxford.
|
| |
| 166. |
Chapman, R., Sidrauski, C., and Walter, P. (1998) Intracellular signaling from the endoplasmic reticulum to the nucleus. Annu. Rev. Cell. Dev. Biol.
14, 459–485.
|
| |
| 167. |
Kaufman, R. J. (1999) Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and
translational controls. Genes Dev.
13, 1211–1233.
|
| |
| 168. |
Kozutsumi, Y., Segal, M., Normington, K., Gething, M. J., and Sambrook, J. (1988) The presence of malfolded proteins in the
endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature
332, 462–464.
|
| |
| 169. |
Wooden, S. K., Li, L. J., Navarro, D., Qadri, I., Pereira, L., and Lee, A. S. (1991) Transactivation of the grp78 promoter
by malfolded proteins, glycosylation block, and calcium ionophore is mediated through a proximal region containing a CCAAT
motif which interacts with CTF/NF-I. Mol. Cell. Biol.
11, 5612–5623.
|
| |
| 170. |
Miyata, T., Kokame, K., Agarwala, K.L., and Kato, H. (1998) Analysis of gene expression in homocysteine-injured vascular endothelial
cells: demonstration of GRP78/BiP expression, cloning and characterization of a novel reducing agent-tunicamycin regulated
gene. Semin. Thromb. Hemost.
24, 285–291.
|
| |
| 171. |
Cao, X., Zhou, Y., and Lee, A. S. (1995) Requirement of tyrosine-and serine/threonine kinases in the transcriptional activation
of the mammalian grp78/BiP promoter by thapsigargin. J. Biol. Chem.
270, 494–502.
|
| |
| 172. |
Tully, D. B., Collins, B. J., Overstreet, J. D., et al. (2000) Effects of arsenic, cadmium, chromium, and lead on gene expression
regulated by a battery of 13 different promoters in recombinant HepG2 cells. Toxicol. Appl. Pharmacol.
168, 79–90.
|
| |
| 173. |
Fernandez, P. M., Tabbara, S. O., Jacobs, L. K., et al. (2000) Overexpression of the glucose-regulated stress gene GRP78 in
malignant but not benign human breast lesions. Breast Cancer Res. Treat.
59, 15–26.
|
| |
| 174. |
Liu, H., Miller, E., van de Water, B., and Stevens, J. L. (1998) Endoplasmic reticulum stress proteins block oxidant-induced
Ca2+ increases and cell death. J. Biol. Chem.
273, 12,858–12,862.
|
| |
| 175. |
Norenberg, M. (1996) Reactive astrocytosis, in The Role of Glia in Neurotoxicity (Aschner, M. and Kimelberg, H. K., eds.), CRC, Boca Raton, FL, pp. 93–107.
|
| |
| 176. |
Stoltenburg-Didinger, I., Pünder, B., Peters, M., et al. (1996) Glial fibrillary acidic protein and RNA expression in adult
rat hippocampus following lowlevel lead exposure during development. Histochem. Cell Biol.
105, 431–442.
|
| |
| 177. |
Harry, G. J., Schmitt, T. J., Gong, Z., Brown, H., Zawia, N., and Evans, H. L. (1996) Lead-induced alterations of glial fibrillary
acidic protein (GFAP) in the developing rat brain. Toxicol. Appl. Pharmacol.
139, 84–93.
|
| |
| 178. |
Selvin-Testa, A., Loidl, C. F., Lopez, E. M., Capani, F., Lopez-Costa, J. J., and Pecci-Saavedra, J. (1995) Prolonged lead
exposure modifies astrocyte cytoskeletal proteins in the rat brain. Neurotoxicology
16, 389–401.
|
| |
| 179. |
Struzyñska, L. Bubko, I., Walski, M., and Rafalwska, U. (2001) Astroglial reaction during the early phase of acute lead toxicity
in the adult rat brain. Toxicology
165, 121–131.
|
| |